Diagnostic Performance of Fluorine-18-Fluorodeoxyglucose Positron Emission Tomography in the Postchemotherapy Management of Patients with Seminoma: Systematic Review and Meta-Analysis

Article, Review English OPEN
Treglia, Giorgio; Sadeghi, Ramin; Annunziata, Salvatore; Caldarella, Carmelo; Bertagna, Francesco; Giovanella, Luca;
(2014)

Objective. To meta-analyze published data about the diagnostic performance of fluorine-18-Fluorodeoxyglucose (18F-FDG) positron emission tomography (PET) and PET/computed tomography (PET/CT) in the postchemotherapy management of patients with seminoma. Methods. A compre... View more
  • References (28)
    28 references, page 1 of 3

    Nallu, A., Mannuel, H. D., Hussain, A.. Testicular germ cell tumors: biology and clinical update. Current Opinion in Oncology. 2013; 25: 266-272

    Daneshmand, S., Albers, P., Fosså, S. D.. Contemporary management of postchemotherapy testis cancer. European Urology. 2012; 62 (5): 867-876

    Quek, M. L., Simma-Chiang, V., Stein, J. P., Pinski, J., Quinn, D. I., Skinner, D. G.. Postchemotherapy residual masses in advanced seminoma: current management and outcomes. Expert Review of Anticancer Therapy. 2005; 5 (5): 869-874

    Treglia, G., Cason, E., Fagioli, G.. Recent applications of nuclear medicine in diagnostics (I part). Italian Journal of Medicine. 2010; 4 (2): 84-91

    Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., Moher, D.. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Journal of Clinical Epidemiology. 2009; 62 (10): e1-e34

    Ambrosini, V., Zucchini, G., Nicolini, S.. 18F-FDG PET/CT impact on testicular tumours clinical management. European Journal of Nuclear Medicine and Molecular Imaging. 2014; 41 (4): 668-673

    Bachner, M., Loriot, Y., Gross-Goupil, M., Zucali, P. A., Horwich, A., Germa-lluch, J.-R., Kollmannsberger, C., Stoiber, F., Fléchon, A., Oechsle, K., Gillessen, S., Oldenburg, J., Cohn-cedermark, G., Daugaard, G., Morelli, F., Sella, A., Harland, S., Kerst, M., Gampe, J., Dittrich, C., Fizazi, K., De Santis, M.. 2-18fluoro-deoxy-D-glucose positron emission tomography (FDG-PET) for postchemotherapy seminoma residual lesions: a retrospective validation of the SEMPET trial. Annals of Oncology. 2012; 23 (1): 59-64

    Siekiera, J., Małkowski, B., Jóźwicki, W.. Can we rely on PET in the follow-up of advanced seminoma patients?. Urologia Internationalis. 2012; 88 (4): 405-409

    Hinz, S., Schrader, M., Kempkensteffen, C.. The role of positron emission tomography in the evaluation of residual masses after chemotherapy for advanced stage seminoma. The Journal of Urology. 2008; 179 (3): 936-940

    Lewis, D. A., Tann, M., Kesler, K., McCool, A., Foster, R. S., Einhorn, L. H.. Positron emission tomography scans in postchemotherapy seminoma patients with residual masses: a retrospective review from Indiana University Hospital. Journal of Clinical Oncology. 2006; 24 (34): e54-e55

  • Related Research Results (1)
  • Related Organizations (3)
  • Metrics
Share - Bookmark